5 Best Healthcare Stocks to Buy According to Matthew Halbower’s Pentwater Capital Management

3. Poseida Therapeutics, Inc. (NASDAQ:PSTX)

Halbower’s Stake Value: $49.7 million
Percentage of Matthew Halbower’s 13F Portfolio: 0.41%

Poseida Therapeutics, Inc. (NASDAQ:PSTX) is a clinical-stage biopharmaceutical company that focuses on the development of therapeutics for patients with high unmet medical needs. Ranked 3rd on the list of the 10 best healthcare stocks to buy according to Matthew Halbower’s Pentwater Capital Management, Poseida Therapeutics, Inc. (NASDAQ:PSTX) has a market capitalization of $498.71 million.

Matthew Halobwer’s Pentwater Capital Management currently owns more than 4.96 million shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) amounting to $49.77 million in worth and representing 0.41% of the fund’s total portfolio. Poseida Therapeutics, Inc. (NASDAQ:PSTX) last released their quarterly earnings for the second quarter of 2021 on August 12, with reported earnings per share at -$0.74, missing the estimated earnings per share of -$0.64 by $0.10.

Out of the hedge funds being tracked by Insider Monkey, Boston-based investment firm Adage Capital Management  is a leading shareholder in Poseida Therapeutics, Inc. (NASDAQ:PSTX) with over 1.27 million shares worth more than $12.77 million.